Navigation Links
Echo Therapeutics Hires Product Development Management Executive
Date:1/14/2014

PHILADELPHIA, Jan. 14, 2014 /PRNewswire/ -- Echo Therapeutics, Inc. (Nasdaq: ECTE) ("Echo"), a medical device company developing its Symphony® CGM System as a non-invasive, wireless continuous glucose monitoring system, today announced that Thomas Bishop has joined Echo Therapeutics' management team as Vice President of Product Development. Mr. Bishop, an accomplished product development executive with more than thirty years' experience, joins Echo at a critical stage in the Company's growth.  He will lead the execution of Echo's product roadmap strategy and reports directly to Robert F. Doman, Echo's Executive Chairman and Interim CEO.

"Tom joins Echo at an important and exciting time. We are extremely pleased to have such a highly valuable, proven industry leader join the company as we move toward Symphony's commercialization," said Mr. Doman. "Tom's product development expertise and successful track record in developing complex medical devices will help support Echo's goal of attaining regulatory clearance and bringing our Symphony CGM System to market. I have great confidence in Tom's ability to take us into the next phase of our product development process."

Mr. Bishop brings over thirty years of experience leading the development of high technology products for the medical device, networking and military industries. Prior to joining Echo, Mr. Bishop was a Senior Director of Control Systems at iWalk, Inc. where he led a multidisciplinary team in the development of a robotic prosthetic and provided a strategic product roadmap. Prior to that, Mr. Bishop held the positions of Vice President of Advanced Development and Vice President of Engineering for TransMedics, where he led the development of revolutionary devices that maintained human hearts and lungs in a fun
'/>"/>

SOURCE Echo Therapeutics, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2

Related medicine technology :

1. Cell Therapeutics, Inc. (CTI) to Report First Quarter Financial Results on April 20
2. Faruqi & Faruqi, LLP Encourages Investors Who Suffered Substantial Losses Investing in Chelsea Therapeutics International, Ltd. to Contact the Firm
3. Argos Therapeutics Secures $25 million Series D Financing to Commence Phase 3 ADAPT Study in Patients with Metastatic Renal Cell Carcinoma (mRCC) in Mid-2012
4. Novelos Therapeutics Announces Successful Completion of First Cohort In Lung Cancer Trial With I-124-CLR1404 (LIGHT) Cancer-Targeted PET Imaging Agent at UW Carbone Cancer Center
5. Zacks Industry Outlook Highlights: Eli Lilly, Forest Labs, ViroPharma, Novartis and United Therapeutics
6. Oxford BioTherapeutics Appoints Senior Industry Leader to Head its New Clinical Development Operations in Basel, Switzerland
7. Nektar Therapeutics Reports Financial Results for the First Quarter of 2012
8. Cara Therapeutics Licenses Novel Kappa Opioid Agonist, CR845, to Chong Kun Dang Pharmaceutical Corporation For South Korean Market
9. Frost & Sullivan: High Uptake of New Drug Therapies and Aging Population Expansion Keep the U.S. Retinal Therapeutics Market Buoyant
10. Zenobia Therapeutics, Inc. And BioBlocks, Inc. Announce Sale Of A Joint Fragment Library Ideal For Screening By All Popular Methods
11. New Forecast Shows Global Protein Therapeutics Market to Reach $143.4 Billion by 2015
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/21/2014)... 2014   Auxilium Pharmaceuticals, Inc. (NASDAQ: ... today announced positive results from a randomized, double-blind ... CCH) for the treatment of edematous fibrosclerotic panniculopathy ... 2a trial, all three doses of CCH (low ... improvement in the appearance of cellulite as measured ...
(Date:8/20/2014)... Aug. 20, 2014  The National Association of ... results achieved by the real-time, pseudoephedrine (PSE) blocking ... Precursor Log Exchange (NPLEx), automatically blocks unlawful PSE ... meth offenders and make arrests. Data released by ... blocked the sale of more than ...
(Date:8/20/2014)... The National Association of Drug Diversion ... by the real-time, pseudoephedrine (PSE) blocking system in ... Exchange (NPLEx), automatically blocks unlawful pseudoephedrine sales and ... and make arrests. Data released by NPLEx shows ... blocked the sale of more than 7,481 boxes of ...
Breaking Medicine Technology:Auxilium Pharmaceuticals, Inc. Announces Positive Data From Phase 2a Study Of CCH In Patients With Cellulite 2Auxilium Pharmaceuticals, Inc. Announces Positive Data From Phase 2a Study Of CCH In Patients With Cellulite 3Auxilium Pharmaceuticals, Inc. Announces Positive Data From Phase 2a Study Of CCH In Patients With Cellulite 4Auxilium Pharmaceuticals, Inc. Announces Positive Data From Phase 2a Study Of CCH In Patients With Cellulite 5Auxilium Pharmaceuticals, Inc. Announces Positive Data From Phase 2a Study Of CCH In Patients With Cellulite 6Auxilium Pharmaceuticals, Inc. Announces Positive Data From Phase 2a Study Of CCH In Patients With Cellulite 7Indiana's Stop-Sale System Achieves Significant Results In Battle Against Meth 2Kansas's Stop-Sale System Achieves Significant Results In Battle Against Meth 2
... of Advanced Medical Center, Licensed to ... Administer PROMETA(R), ... use, Dr. Gregory Ellison, Director of Advanced Medical,Center, has identified a ... is performed on an out-patient (versus,in-patient) basis in 10 hours over ...
... Upcoming ECCMID Conference, REINACH, Switzerland, April 11 ... April, Arpida Ltd. (SWX: ARPN) today,elaborates on some ... in complicated Skin and Skin Structure Infections,(cSSSI). Extensive ... year,s ICAAC,and IDSA meetings. Data on ASSIST-2 will ...
Cached Medicine Technology:Arizona Doctor Offers New Addiction Drug Treatment for Meth Addicts Showing More Than 60% Success Rate 2Arizona Doctor Offers New Addiction Drug Treatment for Meth Addicts Showing More Than 60% Success Rate 3Arpida Provides Further Comments on the Pivotal Phase III Trials 2Arpida Provides Further Comments on the Pivotal Phase III Trials 3Arpida Provides Further Comments on the Pivotal Phase III Trials 4
(Date:8/21/2014)... Not only is eating better and exercising healthy for people ... a year, a new study finds. The study, led ... Wake Forest Baptist Medical Center in Winston-Salem, N.C., included ... Participants ranged in age from 45 to ... change program" focused on diet and exercise, or to a ...
(Date:8/21/2014)... HealthDay Reporter THURSDAY, Aug. 21, ... antidepressants appears to best help people with severe but ... of five people suffering from severe depression for less ... cognitive therapy plus antidepressant medication, researchers found. On ... than drugs alone in helping people with mild depression ...
(Date:8/21/2014)... A new study published this week in ... associated with speech problems from 2001-02 to 2010-11 among ... in disability associated with hearing problems. The data underscore ... children who are experiencing communication disorders, according to the ... a broader level, the new study, Changing Trends ...
(Date:8/21/2014)... in rural communities do not routinely screen women ... State medical and public health researchers. Rural women ... resources if they seek help., "Rural health care ... Jennifer S. McCall-Hosenfeld, a primary care physician and ... Penn State College of Medicine. "However, in rural ...
(Date:8/21/2014)... York (PRWEB) August 21, 2014 Xarelto ... thinner caused patients to suffer uncontrollable internal bleeding and ... Bernstein Liebhard LLP reports. According to court documents, a ... U.S. District Court, Easter District of New York by ... to a bleeding event that was allegedly caused by ...
Breaking Medicine News(10 mins):Health News:Getting Healthier a Big Money-Saver for People With Diabetes 2Health News:Talk Therapy Plus Meds May Be Best for Severe Depression 2Health News:Talk Therapy Plus Meds May Be Best for Severe Depression 3Health News:New Pediatrics Study Reveals Dramatic Increase in Speech Problems in Children Over Past Decade 2Health News:New Pediatrics Study Reveals Dramatic Increase in Speech Problems in Children Over Past Decade 3Health News:Primary care physicians can be critical resource for abused women in rural areas 2Health News:Xarelto Lawsuits Mount With New Filing in New York Federal Court, Bernstein Liebhard LLP Reports 2Health News:Xarelto Lawsuits Mount With New Filing in New York Federal Court, Bernstein Liebhard LLP Reports 3Health News:Xarelto Lawsuits Mount With New Filing in New York Federal Court, Bernstein Liebhard LLP Reports 4
... With ... Disabilities, CHICAGO, ... its 27th annual ,Cones for Kids, Valentine,s Day,fundraiser to benefit Easter ... just over $616,000 to help,children and adults with disabilities in 16 ...
... and Company,(NYSE: LLY ) today announced that ... FORSTEO(R) (teriparatide [rDNA origin] injection) for the,treatment of ... and men at increased risk for fracture.,This approval ... by,the Committee for Medicinal Products for Human Use ...
... Milestone Coincides with Visit from Legendary Recording Artist ... The California Science,Center welcomed the 1-millionth visitor ... in what has been a record-breaking run for ... Exposition Park. Grammy,Award-winning recording artist Chaka Khan and ...
... aftereffects reverberate long after the incidents , , THURSDAY, April ... male partner violence suffer a wide range of physical ... study that included 25,000 women in 11 countries. , ... Brazil, Ethiopia, Japan, Namibia, Peru, Samoa, Serbia and Montenegro, ...
... is,pleased to join Harvard University,s Ash Institute for ... bi-annual conference,Frontiers of Innovation: 20 Years of Innovation ... On Monday evening, the executive,director of the Pan ... discussed multisector partnerships in tackling neglected,diseases and in ...
... -- time between births can be risky, research suggests , , THURSDAY, ... When is the right time to have your first child? , ... when to have the next baby -- if you decide to ... say, can decrease your risk of having a baby born premature ...
Cached Medicine News:Health News:Friendly's Dishes Out $616,000 for Easter Seals 2Health News:FORSTEO(R) Receives Approval from the European Commission for the Treatment of Glucocorticoid-Induced Osteoporosis 2Health News:FORSTEO(R) Receives Approval from the European Commission for the Treatment of Glucocorticoid-Induced Osteoporosis 3Health News:FORSTEO(R) Receives Approval from the European Commission for the Treatment of Glucocorticoid-Induced Osteoporosis 4Health News:FORSTEO(R) Receives Approval from the European Commission for the Treatment of Glucocorticoid-Induced Osteoporosis 5Health News:California Science Center Welcomes 1-Millionth BODY WORLDS Visitor 2Health News:Male Partner Violence Hurts Women's Health Worldwide 2Health News:PAHEF Discusses Neglected Diseases and Disaster Preparedness with Innovative Leaders 2Health News:When It Comes to Pregnancy, Timing Is Everything 2Health News:When It Comes to Pregnancy, Timing Is Everything 3
... Viscoelastic System is designed to give two ... can be used differently and sequentially to ... The choice of the viscoelastic is based ... of each to facilitate performance of the ...
... a product comes along that forever raises ... category. The new StealthStation TREON plus Treatment ... Built on the phenomenal success of the ... system in the worldthe new TREON plus ...
... and the FF 450plus Fundus Camera are ... of accuracy and security that can't be ... Without this level of integrated synergy, calibration ... VISUPAC system pixel for pixel, the FF ...
The new Riata® i lead family allows physicians even more versatility when managing patients with high defibrillation thresholds (DFTs)....
Medicine Products: